{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T06:43:21Z","timestamp":1779345801827,"version":"3.51.4"},"reference-count":22,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2001,5,1]],"date-time":"2001-05-01T00:00:00Z","timestamp":988675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":4460,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Biology"],"published-print":{"date-parts":[[2001,5]]},"DOI":"10.1016\/s0960-9822(01)00225-1","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T22:04:50Z","timestamp":1027634690000},"page":"764-768","source":"Crossref","is-referenced-by-count":300,"title":["Tumor suppressor and anti-inflammatory actions of PPAR\u03b3 agonists are mediated via upregulation of PTEN"],"prefix":"10.1016","volume":"11","author":[{"given":"Lisa","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Pass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phil","family":"Coxon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.Peter","family":"Downes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen A.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin H.","family":"Macphee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0960-9822(01)00225-1_BIB1","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0092-8674(00)80674-1","article-title":"The multiple roles of PTEN in tumor suppression","volume":"100","author":"Di Cristofano","year":"2000","journal-title":"Cell"},{"key":"10.1016\/S0960-9822(01)00225-1_BIB2","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/35013000","article-title":"Roles of PPARs in health and disease","volume":"405","author":"Kersten","year":"2000","journal-title":"Nature"},{"key":"10.1016\/S0960-9822(01)00225-1_BIB3","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/2030","article-title":"Differentiation and reversal of malignant changes in colon cancer through PPAR\u03b3","volume":"4","author":"Sarraf","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/S0960-9822(01)00225-1_BIB4","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S1097-2765(01)80012-5","article-title":"Loss-of-function mutations in PPAR \u03b3 associated with human colon cancer","volume":"3","author":"Sarraf","year":"1999","journal-title":"Mol Cell"},{"key":"10.1016\/S0960-9822(01)00225-1_BIB5","doi-asserted-by":"crossref","first-page":"8806","DOI":"10.1073\/pnas.95.15.8806","article-title":"Ligands for peroxisome proliferator-activated receptor\u03b3 and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice","volume":"95","author":"Elstner","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0960-9822(01)00225-1_BIB6","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0962-8924(99)01519-6","article-title":"Pten","volume":"9","author":"Maehama","year":"1999","journal-title":"Trends Cell Biol"},{"key":"10.1016\/S0960-9822(01)00225-1_BIB7","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/35154","article-title":"PPAR-\u03b3 agonists inhibit production of monocyte inflammatory cytokines","volume":"391","author":"Jiang","year":"1998","journal-title":"Nature"},{"key":"10.1016\/S0960-9822(01)00225-1_BIB8","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/34178","article-title":"The peroxisome proliferator-activated receptor-\u03b3 is a negative regulator of macrophage activation","volume":"391","author":"Ricote","year":"1998","journal-title":"Nature"},{"key":"10.1016\/S0960-9822(01)00225-1_BIB9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0002-9440(10)65540-X","article-title":"Macrophages in human atheroma contain PPAR\u03b3","volume":"153","author":"Marx","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1016\/S0960-9822(01)00225-1_BIB10","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/22572","article-title":"Interleukin-4-dependent production of PPAR-\u03b3 ligands in macrophages by 12\/15-lipoxygenase","volume":"400","author":"Huang","year":"1999","journal-title":"Nature"},{"key":"10.1016\/S0960-9822(01)00225-1_BIB11","first-page":"751","article-title":"Identification of high-affinity binding sites for the insulin sensitizer rosiglitazone (BRL-49653) in rodent and human adipocytes using a radioiodinated ligand for peroxisomal proliferator-activated receptor \u03b3","volume":"284","author":"Young","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/S0960-9822(01)00225-1_BIB12","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0014-5793(98)01255-1","article-title":"The SH2 domain containing inositol 5-phosphatase SHIP2 displays phosphatidylinositol 3,4,5-trisphosphate and inositol 1,3,4,5-tetrakisphosphate 5-phosphatase activity","volume":"437","author":"Pesesse","year":"1998","journal-title":"FEBS Lett"},{"key":"10.1016\/S0960-9822(01)00225-1_BIB13","doi-asserted-by":"crossref","first-page":"35963","DOI":"10.1074\/jbc.274.50.35963","article-title":"Distinct phosphatidylinositol 3-kinase lipid products accumulate upon oxidative and osmotic stress and lead to different cellular responses","volume":"274","author":"Van der Kaay","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/S0960-9822(01)00225-1_BIB14","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1042\/bj3460561","article-title":"The PI3K-PDK1 connection","volume":"3","author":"Vanhaesebroeck","year":"2000","journal-title":"Biochem J"},{"key":"10.1016\/S0960-9822(01)00225-1_BIB15","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0955-0674(99)80029-5","article-title":"Signalling through phosphoinositide 3-kinases","volume":"11","author":"Leevers","year":"1999","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/S0960-9822(01)00225-1_BIB16","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1074\/jbc.M009134200","article-title":"The tumor suppressor PTEN is phosphorylated by the protein kinase CK2 at its C terminus. Implications for PTEN stability to proteasome-mediated degradation","volume":"276","author":"Torres","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/S0960-9822(01)00225-1_BIB17","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1126\/science.285.5436.2122","article-title":"Impaired Fas response and autoimmunity in Pten+\/\u2212 mice","volume":"285","author":"Di Cristofano","year":"1999","journal-title":"Science"},{"key":"10.1016\/S0960-9822(01)00225-1_BIB18","doi-asserted-by":"crossref","first-page":"14306","DOI":"10.1074\/jbc.274.20.14306","article-title":"Membrane-targeted phosphatidylinositol 3-kinase mimics insulin actions and induces a state of cellular insulin resistance","volume":"274","author":"Egawa","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/S0960-9822(01)00225-1_BIB19","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/81715","article-title":"Hypoglycaemia, liver necrosis and perinatal death in mice lacking all isoforms of phosphoinositide 3-kinase p85 \u03b1","volume":"26","author":"Fruman","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/S0960-9822(01)00225-1_BIB20","doi-asserted-by":"crossref","first-page":"10990","DOI":"10.1073\/pnas.180329197","article-title":"Effects of ligand activation of peroxisome proliferator-activated receptor \u03b3 in human prostate cancer","volume":"97","author":"Mueller","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0960-9822(01)00225-1_BIB21","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1073\/pnas.96.7.3951","article-title":"Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-\u03b3 ligand troglitazone in patients with liposarcoma","volume":"96","author":"Demetri","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0960-9822(01)00225-1_BIB22","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1172\/JCI10370","article-title":"Peroxisome proliferator-activated receptor \u03b3 ligands inhibit development of atherosclerosis in LDL receptor-deficient mice","volume":"106","author":"Li","year":"2000","journal-title":"J Clin Invest"}],"container-title":["Current Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960982201002251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960982201002251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T02:57:37Z","timestamp":1681441057000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960982201002251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,5]]},"references-count":22,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2001,5]]}},"alternative-id":["S0960982201002251"],"URL":"https:\/\/doi.org\/10.1016\/s0960-9822(01)00225-1","relation":{},"ISSN":["0960-9822"],"issn-type":[{"value":"0960-9822","type":"print"}],"subject":[],"published":{"date-parts":[[2001,5]]}}}